Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Westmead, NSW, 2145, Australia.
Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Hepatol Int. 2020 Dec;14(6):889-919. doi: 10.1007/s12072-020-10094-2. Epub 2020 Oct 1.
Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver disease and affects nearly a quarter of the global population. The objective of this work was to present the clinical practice guidelines of the Asian Pacific Association for the Study of the Liver (APASL) on MAFLD. The guidelines cover various aspects of MAFLD including its epidemiology, diagnosis, screening, assessment, and treatment. The document is intended for practical use and for setting the stage for advancing clinical practice, knowledge, and research of MAFLD in adults, with specific reference to special groups as necessary. The guidelines also seek to improve patient care and awareness of the disease and assist stakeholders in the decision-making process by providing evidence-based data. The guidelines take into consideration the burden of clinical management for the healthcare sector.
代谢相关性脂肪性肝病（MAFLD）是全球范围内导致肝脏疾病的主要原因，影响了近全球四分之一的人口。本项工作旨在介绍亚太肝病学会（APASL）关于 MAFLD 的临床实践指南。该指南涵盖了 MAFLD 的多个方面，包括其流行病学、诊断、筛查、评估和治疗。该文件旨在实际应用，并为推进成人 MAFLD 的临床实践、知识和研究奠定基础，必要时还特别针对特殊人群。该指南还旨在通过提供基于证据的数据来改善患者对该疾病的认识和护理，并协助利益相关者在决策过程中的工作。该指南考虑到了医疗保健部门临床管理的负担。
